Title |
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
|
Institution |
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC, BOSTON, MA
|
Principal Investigator |
COMIS, ROBERT
|
NCI Program Director |
Jeffrey Abrams
|
Cancer Activity |
Clinical Trials
|
Division |
DCTD
|
Funded Amount |
$8,568,903
|
Project Dates |
09/01/1992 - 04/30/2010
|
Fiscal Year |
2007
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer Survivorship (19.0%)
Chemotherapy (100.0%)
Digestive Diseases (11.0%)
Hematology (8.0%)
Interferon (10.0%)
Orphan Drug Research (9.0%)
Surgery (11.0%)
Taxol (17.0%)
|
Breast (26.0%)
Colon/Rectum (10.0%)
Head and Neck (Subset of Total Head and Neck) (3.0%)
Leukemia (8.0%)
Lung (10.0%)
Multiple Myeloma (5.0%)
Non Hodgkins lymphoma (6.0%)
Prostate (1.0%)
|
Research Type |
Localized Therapies - Clinical Applications
Systemic Therapies - Clinical Applications
|
Abstract |
DESCRIPTION (provided by applicant): This Interim Review application requests funding for those components of the Eastern Cooperative Oncology Group (ECOG) that did not receive full funding for six years at the time of the last competing application. Funding is requested to support the GU and Myeloma Committees, the Leukemia Lab Subcommittee, the Leukemia Core Laboratories, and the ECOG Pathology Coordinating Office through the end of the current competing cycle. |